NVRO | | NEVRO CORP | GROSSMAN D KEITH | Director | Apr 11, 2024 | Option Exercise | $13.12 | 3,986 | 52,296 | 211,444 | Apr 15, 2024, 04:08 PM |
NVRO | | NEVRO CORP | Rashid Kashif | SVP, Corp Dev and CLO | Apr 04, 2024 | Option Exercise | $13.21 | 479 | 6,328 | 165,983 | Apr 08, 2024, 04:15 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Director | Mar 11, 2024 | Option Exercise | $14.99 | 2,184 | 32,738 | 215,430 | Mar 13, 2024, 04:27 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 07, 2024 | Option Exercise | $15.32 | 7,045 | 107,929 | 166,462 | Mar 11, 2024, 04:52 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Mar 07, 2024 | Option Exercise | $15.32 | 7,136 | 109,324 | 140,704 | Mar 11, 2024, 04:50 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Mar 07, 2024 | Option Exercise | $15.32 | 2,706 | 41,456 | 50,646 | Mar 11, 2024, 04:49 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Director | Mar 04, 2024 | Option Exercise | $14.51 | 1,597 | 23,172 | 217,614 | Mar 06, 2024, 06:27 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Mar 04, 2024 | Option Exercise | $14.51 | 438 | 6,355 | 63,514 | Mar 06, 2024, 06:25 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Mar 04, 2024 | Option Exercise | $14.51 | 125 | 1,814 | 36,486 | Mar 06, 2024, 06:23 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 04, 2024 | Option Exercise | $14.51 | 425 | 6,167 | 89,181 | Mar 06, 2024, 06:23 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Feb 28, 2024 | Option Exercise | $14.82 | 898 | 13,308 | 64,479 | Mar 01, 2024, 05:56 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Feb 28, 2024 | Option Exercise | $14.82 | 898 | 13,308 | 90,653 | Mar 01, 2024, 05:55 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Jan 04, 2024 | Option Exercise | $19.39 | 526 | 10,199 | 91,551 | Jan 08, 2024, 05:25 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Dec 01, 2023 | Option Exercise | $18.82 | 229 | 4,310 | 37,224 | Dec 05, 2023, 05:16 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Director | Dec 03, 2023 | Option Exercise | $18.82 | 2,056 | 38,694 | 215,864 | Dec 05, 2023, 05:15 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Nov 28, 2023 | Option Exercise | $16.67 | 800 | 13,336 | 92,077 | Nov 30, 2023, 04:59 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Nov 28, 2023 | Option Exercise | $16.67 | 800 | 13,336 | 65,377 | Nov 30, 2023, 04:56 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Nov 11, 2023 | Option Exercise | $15.04 | 230 | 3,459 | 37,453 | Nov 14, 2023, 06:54 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Executive Chairman | Oct 24, 2023 | Option Exercise | $15.75 | 6,012 | 94,689 | 217,920 | Oct 26, 2023, 04:34 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Oct 04, 2023 | Option Exercise | $18.07 | 1,879 | 33,954 | 92,877 | Oct 06, 2023, 05:14 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Sep 01, 2023 | Option Exercise | $20.39 | 228 | 4,649 | 25,104 | Sep 06, 2023, 05:50 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Executive Chairman | Sep 03, 2023 | Option Exercise | $20.39 | 2,193 | 44,715 | 223,932 | Sep 06, 2023, 05:49 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Aug 28, 2023 | Option Exercise | $19.39 | 800 | 15,512 | 66,177 | Aug 30, 2023, 04:49 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Aug 28, 2023 | Option Exercise | $19.39 | 800 | 15,512 | 94,756 | Aug 30, 2023, 04:48 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Executive Chairman | Jul 24, 2023 | Option Exercise | $24.16 | 6,013 | 145,274 | 226,125 | Jul 26, 2023, 04:35 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Jun 15, 2023 | Option Exercise | $24.97 | 1,585 | 39,577 | 66,977 | Jun 20, 2023, 05:23 PM |
NVRO | | NEVRO CORP | McCormick Shawn | Director | Jun 07, 2023 | Buy | $22.88 | 7,500 | 171,633 | 26,866 | Jun 09, 2023, 04:37 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Jun 04, 2023 | Option Exercise | $28.27 | 450 | 12,722 | 95,556 | Jun 06, 2023, 04:41 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Executive Chairman | Jun 03, 2023 | Option Exercise | $28.27 | 2,193 | 61,996 | 232,138 | Jun 06, 2023, 04:41 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Jun 02, 2023 | Option Exercise | $28.27 | 214 | 6,050 | 25,332 | Jun 05, 2023, 04:43 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Jun 01, 2023 | Option Exercise | $27.43 | 228 | 6,254 | 25,546 | Jun 05, 2023, 04:43 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | May 28, 2023 | Option Exercise | $26.45 | 800 | 21,160 | 68,562 | May 31, 2023, 07:05 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | May 28, 2023 | Option Exercise | $26.45 | 800 | 21,160 | 96,006 | May 31, 2023, 07:03 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | May 28, 2023 | Option Exercise | $26.45 | 1,143 | 30,232 | 85,967 | May 31, 2023, 07:02 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Apr 12, 2023 | Option Exercise | $18.00 | 80,291 | 1,445,238 | 101,018 | Apr 14, 2023, 04:22 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Apr 11, 2023 | Option Exercise | $35.66 | 4,263 | 152,019 | 211,490 | Apr 13, 2023, 04:08 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 11, 2023 | Option Exercise | $30.19 | 2,757 | 83,234 | 215,753 | Mar 14, 2023, 04:18 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 03, 2023 | Option Exercise | $34.43 | 8,798 | 302,915 | 218,510 | Mar 07, 2023, 04:30 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 02, 2023 | Option Exercise | $33.99 | 1,595 | 54,214 | 56,963 | Mar 06, 2023, 06:43 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Mar 02, 2023 | Option Exercise | $33.99 | 1,979 | 67,266 | 47,828 | Mar 06, 2023, 06:43 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Mar 02, 2023 | Option Exercise | $33.99 | 1,133 | 38,511 | 30,080 | Mar 06, 2023, 06:41 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Mar 02, 2023 | Option Exercise | $33.99 | 566 | 19,238 | 12,025 | Mar 06, 2023, 06:40 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Mar 01, 2023 | Option Exercise | $31.61 | 1,023 | 32,337 | 12,591 | Mar 03, 2023, 06:40 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Feb 28, 2023 | Option Exercise | $31.44 | 3,359 | 105,607 | 58,558 | Mar 02, 2023, 04:35 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Feb 28, 2023 | Option Exercise | $31.44 | 4,718 | 148,334 | 49,807 | Mar 02, 2023, 04:34 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Feb 28, 2023 | Option Exercise | $31.44 | 3,352 | 105,387 | 31,213 | Mar 02, 2023, 04:34 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Nov 11, 2022 | Option Exercise | $45.91 | 228 | 10,467 | 13,614 | Nov 15, 2022, 05:02 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Nov 01, 2022 | Option Exercise | $39.30 | 2,134 | 83,866 | 61,917 | Nov 03, 2022, 08:40 PM |
NVRO | | NEVRO CORP | Carter Richard B. | Chief Accounting Officer | Nov 01, 2022 | Option Exercise | $39.30 | 719 | 28,257 | 13,842 | Nov 03, 2022, 08:39 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Aug 06, 2022 | Option Exercise | $47.11 | 4,365 | 205,635 | 54,525 | Aug 08, 2022, 08:26 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Jun 15, 2022 | Option Exercise | $42.25 | 1,579 | 66,713 | 34,565 | Jun 17, 2022, 05:54 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Jun 04, 2022 | Option Exercise | $46.49 | 446 | 20,735 | 53,341 | Jun 07, 2022, 08:40 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | May 09, 2022 | Buy | $44.50 | 2,250 | 100,126 | 53,526 | May 10, 2022, 05:44 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 24, 2022 | Option Exercise | $67.08 | 77,734 | 5,214,397 | 231,571 | Mar 28, 2022, 08:31 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 19, 2022 | Option Exercise | $70.61 | 4,875 | 344,224 | 161,661 | Mar 21, 2022, 08:57 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 11, 2022 | Option Exercise | $64.09 | 2,754 | 176,504 | 166,536 | Mar 15, 2022, 08:05 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 11, 2022 | Buy | $64.04 | 1,500 | 96,067 | 51,276 | Mar 14, 2022, 07:51 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 08, 2022 | Buy | $63.59 | 3,200 | 203,488 | 169,290 | Mar 08, 2022, 09:35 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Mar 02, 2022 | Option Exercise | $71.27 | 2,031 | 144,749 | 58,890 | Mar 04, 2022, 07:14 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Mar 02, 2022 | Option Exercise | $71.27 | 1,186 | 84,526 | 36,144 | Mar 04, 2022, 07:14 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 02, 2022 | Option Exercise | $71.27 | 1,591 | 113,391 | 49,776 | Mar 04, 2022, 07:13 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Jan 02, 2022 | Option Exercise | $81.07 | 1,423 | 115,363 | 33,118 | Jan 04, 2022, 06:06 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Dec 19, 2021 | Option Exercise | $85.81 | 4,874 | 418,238 | 116,090 | Dec 21, 2021, 07:48 PM |
NVRO | | NEVRO CORP | OBOYLE KEVIN C | Director | Dec 14, 2021 | Buy | $83.78 | 2,400 | 201,070 | 13,318 | Dec 16, 2021, 05:58 PM |
NVRO | | NEVRO CORP | WEATHERMAN ELIZABETH H | Director | Nov 22, 2021 | Buy | $85.33 | 20,000 | 1,706,548 | 38,328 | Nov 22, 2021, 06:49 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Nov 11, 2021 | Buy | $101.05 | 2,000 | 202,100 | 34,541 | Nov 15, 2021, 03:03 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Nov 01, 2021 | Option Exercise | $116.26 | 2,137 | 248,448 | 32,541 | Nov 03, 2021, 05:22 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Sep 19, 2021 | Option Exercise | $126.63 | 4,874 | 617,195 | 120,964 | Sep 21, 2021, 06:05 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Aug 13, 2021 | Buy | $105.07 | 7,000 | 735,490 | 125,838 | Aug 17, 2021, 11:36 AM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Aug 06, 2021 | Option Exercise | $119.73 | 4,366 | 522,741 | 34,852 | Aug 10, 2021, 04:27 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Jun 19, 2021 | Option Exercise | $160.45 | 4,874 | 782,033 | 118,838 | Jun 22, 2021, 06:30 PM |
NVRO | | NEVRO CORP | MacLeod Roderick H. | Chief Financial Officer | Jun 15, 2021 | Option Exercise | $158.49 | 1,583 | 250,890 | 19,081 | Jun 16, 2021, 07:02 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Mar 19, 2021 | Option Exercise | $142.81 | 4,873 | 695,913 | 127,975 | Mar 23, 2021, 05:16 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Mar 10, 2021 | Option Exercise | $106.51 | 1,500 | 159,772 | 39,968 | Mar 12, 2021, 05:45 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Mar 02, 2021 | Option Exercise | $168.11 | 706 | 118,686 | 39,218 | Mar 04, 2021, 07:20 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Mar 02, 2021 | Option Exercise | $168.11 | 640 | 107,590 | 34,979 | Mar 04, 2021, 07:19 PM |
NVRO | | NEVRO CORP | Vale Brad | Director | Mar 01, 2021 | Sale | $167.84 | 5,303 | 890,039 | 11,831 | Mar 03, 2021, 12:00 AM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Feb 10, 2021 | Sale | $123.75 | 1,500 | 185,625 | 31,078 | Feb 12, 2021, 05:29 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Jan 11, 2021 | Sale | $117.38 | 1,500 | 176,063 | 31,078 | Jan 13, 2021, 04:18 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Jan 02, 2021 | Option Exercise | $173.10 | 1,365 | 236,282 | 28,483 | Jan 05, 2021, 05:27 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Dec 19, 2020 | Option Exercise | $181.23 | 4,998 | 905,788 | 111,895 | Dec 22, 2020, 05:36 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Dec 10, 2020 | Sale | $113.08 | 1,500 | 169,622 | 31,078 | Dec 14, 2020, 04:38 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Nov 10, 2020 | Option Exercise | $117.85 | 1,500 | 176,775 | 31,078 | Nov 12, 2020, 05:34 PM |
NVRO | | NEVRO CORP | Rashid Kashif | General Counsel | Nov 01, 2020 | Option Exercise | $149.21 | 2,192 | 327,068 | 29,848 | Nov 03, 2020, 04:32 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Oct 22, 2020 | Sale | $165.00 | 1,817 | 299,805 | 30,328 | Oct 26, 2020, 05:11 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Oct 19, 2020 | Sale | $155.00 | 1,000 | 155,000 | 32,145 | Oct 21, 2020, 04:15 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Oct 09, 2020 | Sale | $150.00 | 1,000 | 150,000 | 33,145 | Oct 13, 2020, 06:16 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Oct 13, 2020 | Option Exercise | $108.21 | 1,500 | 162,315 | 33,895 | Oct 13, 2020, 06:16 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Oct 09, 2020 | Sale | $150.31 | 20,529 | 3,085,735 | 237,110 | Oct 13, 2020, 04:35 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Oct 12, 2020 | Sale | $151.21 | 903 | 136,542 | 236,407 | Oct 13, 2020, 04:35 PM |
NVRO | | NEVRO CORP | GROSSMAN D KEITH | Chairman, President & CEO | Sep 19, 2020 | Option Exercise | $142.50 | 4,998 | 712,215 | 116,893 | Sep 22, 2020, 05:38 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Sep 15, 2020 | Sale | $145.27 | 2,000 | 290,546 | 273,468 | Sep 17, 2020, 05:36 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Sep 16, 2020 | Sale | $146.56 | 16,028 | 2,349,040 | 268,466 | Sep 17, 2020, 05:36 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Sep 10, 2020 | Option Exercise | $102.04 | 1,500 | 153,067 | 34,895 | Sep 14, 2020, 04:06 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Sep 02, 2020 | Sale | $145.25 | 3,400 | 493,864 | 275,468 | Sep 04, 2020, 04:14 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Aug 27, 2020 | Sale | $141.01 | 18,900 | 2,665,009 | 289,687 | Aug 31, 2020, 07:15 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Aug 13, 2020 | Sale | $140.05 | 300 | 42,016 | 347,768 | Aug 17, 2020, 04:41 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Aug 10, 2020 | Sale | $135.63 | 4,500 | 610,353 | 40,928 | Aug 12, 2020, 04:32 PM |
NVRO | | NEVRO CORP | DEMANE MICHAEL F | Director | Aug 10, 2020 | Sale | $135.68 | 83,440 | 11,321,168 | 401,039 | Aug 12, 2020, 04:32 PM |
NVRO | | NEVRO CORP | Pellegrini Niamh Louise | Chief Commercial Officer | Aug 06, 2020 | Option Exercise | $141.77 | 4,476 | 634,563 | 34,145 | Aug 10, 2020, 06:55 PM |